Thermo Fisher recently announced it is buying Brammer Bio, which provides viral vector manufacturing services for gene and cell therapy companies. This acquisition is one of the many we have seen recently, as several other large pharmaceutical companies have been acquiring emerging gene and cell therapy companies with promising drug pipelines or drug approvals, including Roche’s acquisition […]
Roche’s acquisition of Spark Therapeutics confirms that gene therapy has finally made its debut as a treatment option for serious diseases Chemotherapy, radiation, and more recently, immunotherapy have been the primary treatments for patients with cancer, and there has been little progress in terms of “huge medical breakthroughs” for cancer treatment for many years. While industry and […]